These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25192047)

  • 1. Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.
    Herrmann DN; Horvath R; Sowden JE; Gonzalez M; Sanchez-Mejias A; Guan Z; Whittaker RG; Almodovar JL; Lane M; Bansagi B; Pyle A; Boczonadi V; Lochmüller H; Griffin H; Chinnery PF; Lloyd TE; Littleton JT; Zuchner S
    Am J Hum Genet; 2014 Sep; 95(3):332-9. PubMed ID: 25192047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
    Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
    Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence.
    Maselli RA; van der Linden H; Ferns M
    Am J Med Genet A; 2020 Jul; 182(7):1744-1749. PubMed ID: 32250532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
    Fionda L; Turon-Sans J; Fuentes Prior P; Bernal Noguera S; Cortés-Vicente E; López-Pérez MA; Gallardo E; Rojas-García R
    J Peripher Nerv Syst; 2021 Mar; 26(1):113-117. PubMed ID: 33320396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.
    Whittaker RG; Herrmann DN; Bansagi B; Hasan BA; Lofra RM; Logigian EL; Sowden JE; Almodovar JL; Littleton JT; Zuchner S; Horvath R; Lochmüller H
    Neurology; 2015 Dec; 85(22):1964-71. PubMed ID: 26519543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome.
    Shields MC; Bowers MR; Fulcer MM; Bollig MK; Rock PJ; Sutton BR; Vrailas-Mortimer AD; Lochmüller H; Whittaker RG; Horvath R; Reist NE
    PLoS One; 2017; 12(9):e0184817. PubMed ID: 28953919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a new SYT2 variant validates an unusual distal motor neuropathy phenotype.
    Montes-Chinea NI; Guan Z; Coutts M; Vidal C; Courel S; Rebelo AP; Abreu L; Zuchner S; Littleton JT; Saporta MA
    Neurol Genet; 2018 Dec; 4(6):e282. PubMed ID: 30533528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels.
    Martin-Moutot N; el Far O; Leveque C; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M; Seagar MJ
    J Physiol Paris; 1993; 87(1):37-41. PubMed ID: 8305896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteins synaptotagmin and syntaxin are not general targets of Lambert-Eaton myasthenic syndrome autoantibody.
    Hajela RK; Atchison WD
    J Neurochem; 1995 Mar; 64(3):1245-51. PubMed ID: 7861157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
    Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic function in patients with hereditary motor and sensory neuropathy type I and Lambert-Eaton myasthenic syndrome.
    Kalmijn S; Oey PL; Wokke JH; Wieneke GH
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):349-53. PubMed ID: 10499205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptotagmin associates with presynaptic calcium channels and is a Lambert-Eaton myasthenic syndrome antigen.
    el Far O; Martin-Moutot N; Leveque C; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M; Seagar MJ
    Ann N Y Acad Sci; 1993 Dec; 707():382-5. PubMed ID: 9137575
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of synaptotagmin with voltage gated calcium channels: a role in Lambert-Eaton myasthenic syndrome?
    David P; Martin-Moutot N; Leveque C; el Far O; Takahashi M; Seagar MJ
    Neuromuscul Disord; 1993; 3(5-6):451-4. PubMed ID: 8186692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5.
    Maselli RA; Arredondo J; Vázquez J; Chong JX; Bamshad MJ; Nickerson DA; Lara M; Ng F; Lo VL; Pytel P; McDonald CM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):119-125. PubMed ID: 29377152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-Eaton syndrome, an unrecognized treatable pediatric neuromuscular disorder: three patients and literature review.
    Hajjar M; Markowitz J; Darras BT; Kissel JT; Srinivasan J; Jones HR
    Pediatr Neurol; 2014 Jan; 50(1):11-7. PubMed ID: 24138947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.